ENV-294

N/A

Report date: 2026/03/06 20:02:51
NMEFirst In Class

Base Information

Drug NameENV-294
Drug Alias NameENV-294
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDermatitis, AtopicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEnveda Biosciences Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDermatitis, AtopicAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A